Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Biotech-IgG Securities (publ) AB
AB
Bankrupt
Org 5590179437
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2015 · 11 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Biotech-IgG Securities (publ) AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HG
Hugo Glenn Renhult
Chief Executive Officer
Chief Executive Officer
2021
Former (4)
KE
Karl Erik Göran Bringer
Audit
Audit
2021 – 2022
LG
Leif Gunnar Skarle
Audit
Audit
2023 – 2023
IT
Ivan Ticic
Chief Auditor
Chief Auditor
2022 – 2024
IE
Isabella Eva Rümmer
Audit
Audit
2021 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
JK
Johan Karl-Herbert Lee Backman
Board of Directors
Board of Directors
2021
PW
Per Wilhelm Wåhlin
Chairman
Chairman
2021
HG
Hugo Glenn Renhult
Board of Directors
Board of Directors
2021
Former (2)
LG
Leif Gustaf Malmborg
Chairman
Chairman
2023 – 2023
IH
Ingemar Håkan Karlsson
Chairman
Chairman
2023 – 2023
Shareholders
As of last annual report
Biotech-IgG Equity AB (publ) — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Biotech-IgG Equity AB (publ)
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Biotech-IgG Securities (publ) AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network